Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration



Status:Archived
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:November 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration


This study will assess the safety, tolerability, and serum pharmacokinetics of intravitreal
LFG316 in patients with advanced age-related macular degeneration.



We found this trial at
8
sites
Retinal Consultants of Arizona
Phoenix, Arizona 85014
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Retina-Vitreous Associates Medical Group
Beverly Hills, California 90211
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Ophthalmic Consultants of Boston
Boston, Massachusetts 02114
?
mi
from
Boston, MA
Click here to add this to my saved trials
Charlotte Eye Ear Nose and Throat Assoc, PA
Charlotte, North Carolina 28210
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Texas Retina Associates
Dallas, Texas 75231
?
mi
from
Dallas, TX
Click here to add this to my saved trials
National Ophthalmic Research Institute
Fort Myers, Florida 33912
?
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Retina Consultants of Houston
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
Center for Retina and Macular Disease
Winter Haven, Florida 33880
?
mi
from
Winter Haven, FL
Click here to add this to my saved trials